RSA I(80449-06-5)
- Name: RSA I
- Synonyms:EndodeoxyribonucleaseRsaI; Endonuclease RsaI; HpyBI restriction endonuclease; Restrictionendodeoxynuclease RsaI; Restriction endodeoxyribonuclease RsaI; Restrictionendodeoxyribonuclease RsaI; Restriction endonuclease AfaI; Restrictionendonuclease AfaI; Restriction endonuclease Csp6I; Restriction endonucleaseCviRII; Restriction endonuclease HpyAXII; Restriction endonuclease HpyBI;Restriction endonuclease PabI; Restriction endonuclease PlaAII; Restrictionendonuclease RsaI; RsaI
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:80449-06-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.80449-06-5 RSA I
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.80449-06-5 RSA I
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:RSA I
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.80449-06-5 RSA I
Assay:95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 5733-50-6/2-oxo-2-[(thiophen-2-ylmethyl)amino]ethyl (naphthalen-2-ylsulfanyl)acetate
- 3804-89-5/2'-(sulphomethyl)isonicotinohydrazide, monosodium salt
- 57529-82-5/2-(6,7-dihydroindolo[1,7-ab][1]benzazepin-1-yl)-N,N-dimethylethanamine
- 63990-32-9/sodium 1,2-dimethyl-10-oxo-4-propyl-8-thioxo-7,9-diazaspiro[4.5]dec-6-en-6-olate
- 32590-21-9/O-2,3,4,6-Tetra-O-acetyl-alpha-D-galactopyranosyl-(1.6)-1,3,4-tri-O-acetyl-beta-D-fructofuranosyl-alpha-D-glucopyranoside tetraacetate
- 50332-32-6/5,6,7,8,9,10-Hexahydro-5-(m-chlorobenzoyl)cyclohepta[b]-1,3-dioxolo[4,5-f]indole
- 54988-40-8/Iron alloy,base,Fe 83-87,Cr 10-12,Ni 1-2,C 1-1.2,Mn 0.7-1,Si 0.3-0.5,Ti 0.2-0.3,N 0.1 (VSN-9)
- 157998-94-2/7,11-Heptadecadienoicacid, 4-methyl-, (7Z,11Z)-
- 124834-79-3/hemoglobin Nouakchott
- 129664-09-1/2-(4-methylpiperazin-1-yl)-4-(pentyloxy)quinazoline (2E)-but-2-enedioate
- 167683-61-6/1-(5-bromopyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl]thiourea
- 70070-08-5/1-[(6,7-dimethoxy-3,4-dihydro-1H-isochromen-1-yl)methyl]-3-(3-fluorophenyl)thiourea
- 5301-21-3/2-[3-(3-methylphenyl)-3-oxo-1-phenylpropyl]-1H-indene-1,3(2H)-dione
- 194150-48-6/2-Propen-1-ol,3-[4-[[(2E)-3,7-dimethyl-2,6- octadienyl]oxy]phenyl]-,(2E)-
- 1668-00-4/ARSENAZO III SODIUM SALT
- 2504-55-4/3'-AMINO-D-ADENOSINE
- 124147-23-5/iso-atrial natriuretic peptide
- 1552-94-9/5-PHENYLPENTA-2,4-DIENOIC ACID
- 189065-53-0/Caloxanthone J
- 80449-06-5/RSA I
- 20041-49-0/1-(propan-2-ylamino)-3-[(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)oxy]propan-2-ol hydrochloride (1:1)
- 11147-60-7/TsN2-A
- 105149-00-6/osaterone acetate
- 96460-79-6/1,4-dihydroxyacridin-9(10H)-one
- 81503-86-8/Newcol B 4SN
- 1054-91-7/1-[4-(2,5-dimethoxyphenyl)-4-hydroxy-4-phenylbutan-2-yl]-1-methylpiperidinium iodide
- 67343-96-8/bis[(1-methyl-5-nitro-1H-imidazol-2-yl)methyl] piperazine-1,4-dicarboxylate
- 158366-57-5/Butanenitrile,2-[[4-chloro-6-(ethylamino)-1,3,5-triazin-2-yl]amino]-2-methyl-, (2S)-
- 73855-61-5/5-(4-methoxybenzylidene)-1,3-thiazolidine-2,4-dione 2-oxime
- 13745-20-5/1-08-00-00707 (Beilstein Handbook Reference)